Related Experiment Video

Updated: Aug 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Inactivation of Myc-induced p53-dependent apoptosis in human tumors

M Henriksson1, G Selivanova, M Lindström

  • 1Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden.

Apoptosis : an International Journal on Programmed Cell Death
|April 26, 2001
PubMed

Insights

The Myc oncoprotein drives cell growth but can also cause cell death through the ARF-p53 pathway. Cancer cells inactivate ARF or p53 to survive, making p53 restoration a potential cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • The Myc family of oncoproteins are key regulators of cell proliferation.
  • Myc overexpression is common in human cancers, promoting tumor growth.
  • Paradoxically, Myc can also induce apoptosis (programmed cell death).

Purpose of the Study:

  • To investigate the role of the ARF-p53 pathway in Myc-induced apoptosis.
  • To understand how cancer cells evade Myc-induced cell death.
  • To explore the therapeutic potential of restoring p53-dependent apoptosis.

Main Methods:

  • Analysis of the ARF-p53 pathway in the context of Myc activation.
  • Investigating mechanisms of resistance to Myc-induced apoptosis in tumor cells.
  • Evaluating strategies to reactivate p53-mediated cell death.

Main Results:

  • Myc activation triggers apoptosis, partly through the ARF-p53 pathway.
  • Tumor cells frequently acquire mutations or deletions in ARF or p53 to survive Myc-driven proliferation.
  • Inactivation of ARF or p53 facilitates tumor progression by enabling survival.

Conclusions:

  • The ARF-p53 pathway is a critical mediator of Myc's dual role in cell growth and death.
  • Acquired resistance to apoptosis, via ARF/p53 inactivation, is essential for Myc-driven tumorigenesis.
  • Restoring p53-dependent apoptosis represents a promising strategy for novel cancer therapies.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...